HEADER SIGNALING PROTEIN 22-JUL-99 1C1Z TITLE CRYSTAL STRUCTURE OF HUMAN BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) CAVEAT 1C1Z NAG B 1 HAS WRONG CHIRALITY AT ATOM C1 MAN D 3 HAS WRONG CAVEAT 2 1C1Z CHIRALITY AT ATOM C1 NAG A 329 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 1C1Z C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA2-GLYCOPROTEIN-I; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD KEYWDS GLYCOPROTEIN, SHORT CONSENSUS REPEAT, SCR, SUSHI DOMAIN, COMPLEMENT KEYWDS 2 CONTROL PROTEIN MODULE, CCP, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.SCHWARZENBACHER,K.ZETH,K.DIEDERICHS,A.GRIES,G.M.KOSTNER,P.LAGGNER, AUTHOR 2 R.PRASSL REVDAT 7 30-OCT-24 1C1Z 1 HETSYN REVDAT 6 29-JUL-20 1C1Z 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 04-OCT-17 1C1Z 1 REMARK REVDAT 4 13-JUL-11 1C1Z 1 VERSN REVDAT 3 24-FEB-09 1C1Z 1 VERSN REVDAT 2 01-APR-03 1C1Z 1 JRNL REVDAT 1 19-NOV-99 1C1Z 0 JRNL AUTH R.SCHWARZENBACHER,K.ZETH,K.DIEDERICHS,A.GRIES,G.M.KOSTNER, JRNL AUTH 2 P.LAGGNER,R.PRASSL JRNL TITL CRYSTAL STRUCTURE OF HUMAN BETA2-GLYCOPROTEIN I: JRNL TITL 2 IMPLICATIONS FOR PHOSPHOLIPID BINDING AND THE JRNL TITL 3 ANTIPHOSPHOLIPID SYNDROME. JRNL REF EMBO J. V. 18 6228 1999 JRNL REFN ISSN 0261-4189 JRNL PMID 10562535 JRNL DOI 10.1093/EMBOJ/18.22.6228 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.SAXENA,A.GRIES,R.SCHWARZENBACHER,G.M.KOSTNER,P.LAGGNER, REMARK 1 AUTH 2 R.PRASSL REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY CRYSTALLOGRAPHIC REMARK 1 TITL 2 STUDIES ON APOLIPOPROTEIN H (BETA-2-GLYCOPROTEIN-I) REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 54 1450 1998 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444998004557 REMARK 2 REMARK 2 RESOLUTION. 2.87 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.87 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 32406 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1608 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.87 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.05 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 60.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3286 REMARK 3 BIN R VALUE (WORKING SET) : 0.3680 REMARK 3 BIN FREE R VALUE : 0.3920 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2541 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 142 REMARK 3 SOLVENT ATOMS : 22 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.11700 REMARK 3 B22 (A**2) : -3.12200 REMARK 3 B33 (A**2) : 10.23900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM SIGMAA (A) : 0.80 REMARK 3 LOW RESOLUTION CUTOFF (A) : 8.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.97 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.57 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.920 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 33.03 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 SIMULATED ANNEALING REFINEMENT WITH MAXIMUM LIKELIHOOD TARGET REMARK 3 USING AMPLITUDES, TORSION ANGLE DYNAMICS, BULK SOLVENT CORRECTION, REMARK 3 ANISOTROPIC B- FACTOR CORRECTION AND GROUPED B-FACTOR REFINEMENT REMARK 3 REMARK 3 SIDE CHAIN POSITIONS OF RESIDUES ARG2, ARG39, LYS59, REMARK 3 LYS110, ARG135, GLN158, LYS177, LYS208, LYS251, REMARK 3 LYS284, GLU285, LYS286, LYS287, LYS308, LEU313 REMARK 3 AND PHE315 ARE POORLY DEFINED REMARK 4 REMARK 4 1C1Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JUL-99. REMARK 100 THE DEPOSITION ID IS D_1000009380. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAY-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32406 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.870 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.87 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.43000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR-MAD COMBINATION REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 84.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 8.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, PHOSPHATE BUFFER, PH REMARK 280 7.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.15000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.15000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 79.75000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 82.40000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 79.75000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 82.40000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 57.15000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 79.75000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 82.40000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 57.15000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 79.75000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 82.40000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP A 316 C - N - CA ANGL. DEV. = -24.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 42 94.92 68.85 REMARK 500 THR A 79 -70.86 -123.46 REMARK 500 PHE A 81 56.35 -63.63 REMARK 500 ARG A 148 13.59 55.76 REMARK 500 CYS A 155 -176.13 -57.75 REMARK 500 LYS A 177 136.65 -34.02 REMARK 500 PRO A 200 142.96 -38.65 REMARK 500 ASP A 217 -52.57 -16.64 REMARK 500 ALA A 252 137.16 -176.66 REMARK 500 ASN A 283 69.68 -110.60 REMARK 500 LYS A 284 -59.55 -1.21 REMARK 500 ASP A 298 74.51 46.94 REMARK 500 ALA A 314 -64.50 -179.14 REMARK 500 PHE A 315 52.16 30.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1VVC RELATED DB: PDB REMARK 900 VACCINA VIRUS COMPLEMENT CONTROL PROTEIN, NMR STRUCTURE OF 2 CCP REMARK 900 MODULES REMARK 900 RELATED ID: 1CKL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 2 CCP (SCR) DOMAINS REMARK 900 RELATED ID: 1HFH RELATED DB: PDB REMARK 900 NMR-STRUCTURE OF 2 CCP MODULES REMARK 900 RELATED ID: 1QUB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GLYCOSYLATED FIVE-DOMAIN HUMAN BETA2- REMARK 900 GLYCOPROTEIN I PURIFIED FROM BLOOD PLASMA DBREF 1C1Z A 1 326 GB 28810 X58100 20 345 SEQRES 1 A 326 GLY ARG THR CYS PRO LYS PRO ASP ASP LEU PRO PHE SER SEQRES 2 A 326 THR VAL VAL PRO LEU LYS THR PHE TYR GLU PRO GLY GLU SEQRES 3 A 326 GLU ILE THR TYR SER CYS LYS PRO GLY TYR VAL SER ARG SEQRES 4 A 326 GLY GLY MET ARG LYS PHE ILE CYS PRO LEU THR GLY LEU SEQRES 5 A 326 TRP PRO ILE ASN THR LEU LYS CYS THR PRO ARG VAL CYS SEQRES 6 A 326 PRO PHE ALA GLY ILE LEU GLU ASN GLY ALA VAL ARG TYR SEQRES 7 A 326 THR THR PHE GLU TYR PRO ASN THR ILE SER PHE SER CYS SEQRES 8 A 326 ASN THR GLY PHE TYR LEU ASN GLY ALA ASP SER ALA LYS SEQRES 9 A 326 CYS THR GLU GLU GLY LYS TRP SER PRO GLU LEU PRO VAL SEQRES 10 A 326 CYS ALA PRO ILE ILE CYS PRO PRO PRO SER ILE PRO THR SEQRES 11 A 326 PHE ALA THR LEU ARG VAL TYR LYS PRO SER ALA GLY ASN SEQRES 12 A 326 ASN SER LEU TYR ARG ASP THR ALA VAL PHE GLU CYS LEU SEQRES 13 A 326 PRO GLN HIS ALA MET PHE GLY ASN ASP THR ILE THR CYS SEQRES 14 A 326 THR THR HIS GLY ASN TRP THR LYS LEU PRO GLU CYS ARG SEQRES 15 A 326 GLU VAL LYS CYS PRO PHE PRO SER ARG PRO ASP ASN GLY SEQRES 16 A 326 PHE VAL ASN TYR PRO ALA LYS PRO THR LEU TYR TYR LYS SEQRES 17 A 326 ASP LYS ALA THR PHE GLY CYS HIS ASP GLY TYR SER LEU SEQRES 18 A 326 ASP GLY PRO GLU GLU ILE GLU CYS THR LYS LEU GLY ASN SEQRES 19 A 326 TRP SER ALA MET PRO SER CYS LYS ALA SER CYS LYS LEU SEQRES 20 A 326 PRO VAL LYS LYS ALA THR VAL VAL TYR GLN GLY GLU ARG SEQRES 21 A 326 VAL LYS ILE GLN GLU LYS PHE LYS ASN GLY MET LEU HIS SEQRES 22 A 326 GLY ASP LYS VAL SER PHE PHE CYS LYS ASN LYS GLU LYS SEQRES 23 A 326 LYS CYS SER TYR THR GLU ASP ALA GLN CYS ILE ASP GLY SEQRES 24 A 326 THR ILE GLU VAL PRO LYS CYS PHE LYS GLU HIS SER SER SEQRES 25 A 326 LEU ALA PHE TRP LYS THR ASP ALA SER ASP VAL LYS PRO SEQRES 26 A 326 CYS MODRES 1C1Z ASN A 143 ASN GLYCOSYLATION SITE MODRES 1C1Z ASN A 164 ASN GLYCOSYLATION SITE MODRES 1C1Z ASN A 174 ASN GLYCOSYLATION SITE MODRES 1C1Z ASN A 234 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NDG B 2 14 HET NAG C 1 14 HET NDG C 2 14 HET BMA C 3 11 HET BMA C 4 11 HET MAN C 5 11 HET NAG D 1 14 HET NAG D 2 14 HET MAN D 3 11 HET NAG A 329 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 2 NAG 5(C8 H15 N O6) FORMUL 2 NDG 2(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN 2(C6 H12 O6) FORMUL 6 HOH *22(H2 O) HELIX 1 1 ILE A 263 PHE A 267 1 5 HELIX 2 2 ASP A 319 VAL A 323 5 5 SHEET 1 A 2 CYS A 4 PRO A 5 0 SHEET 2 A 2 PHE A 21 TYR A 22 -1 N TYR A 22 O CYS A 4 SHEET 1 B 3 SER A 13 VAL A 16 0 SHEET 2 B 3 GLU A 27 CYS A 32 -1 O THR A 29 N VAL A 16 SHEET 3 B 3 LYS A 44 ILE A 46 -1 O PHE A 45 N ILE A 28 SHEET 1 C 2 TYR A 36 SER A 38 0 SHEET 2 C 2 CYS A 60 PRO A 62 -1 N THR A 61 O VAL A 37 SHEET 1 D 4 GLY A 74 ARG A 77 0 SHEET 2 D 4 THR A 86 CYS A 91 -1 N SER A 88 O ARG A 77 SHEET 3 D 4 SER A 102 CYS A 105 -1 O ALA A 103 N ILE A 87 SHEET 4 D 4 TRP A 111 SER A 112 -1 O SER A 112 N LYS A 104 SHEET 1 E 2 PHE A 95 ASN A 98 0 SHEET 2 E 2 VAL A 117 PRO A 120 -1 O VAL A 117 N ASN A 98 SHEET 1 F 2 ILE A 122 CYS A 123 0 SHEET 2 F 2 SER A 145 LEU A 146 -1 N SER A 145 O CYS A 123 SHEET 1 G 3 ALA A 132 VAL A 136 0 SHEET 2 G 3 THR A 150 CYS A 155 -1 O VAL A 152 N ARG A 135 SHEET 3 G 3 THR A 166 THR A 168 -1 N ILE A 167 O ALA A 151 SHEET 1 H 2 HIS A 159 PHE A 162 0 SHEET 2 H 2 GLU A 180 GLU A 183 -1 N GLU A 180 O PHE A 162 SHEET 1 I 2 LYS A 185 CYS A 186 0 SHEET 2 I 2 LEU A 205 TYR A 206 -1 O LEU A 205 N CYS A 186 SHEET 1 J 3 GLY A 195 ASN A 198 0 SHEET 2 J 3 LYS A 210 CYS A 215 -1 O THR A 212 N ASN A 198 SHEET 3 J 3 GLU A 226 GLU A 228 -1 O ILE A 227 N ALA A 211 SHEET 1 K 2 TYR A 219 LEU A 221 0 SHEET 2 K 2 CYS A 241 ALA A 243 -1 N LYS A 242 O SER A 220 SHEET 1 L 4 GLU A 259 LYS A 262 0 SHEET 2 L 4 THR A 253 TYR A 256 -1 N VAL A 254 O VAL A 261 SHEET 3 L 4 LYS A 276 LYS A 282 -1 O SER A 278 N VAL A 255 SHEET 4 L 4 SER A 289 GLN A 295 -1 N TYR A 290 O CYS A 281 SSBOND 1 CYS A 4 CYS A 47 1555 1555 2.48 SSBOND 2 CYS A 32 CYS A 60 1555 1555 2.45 SSBOND 3 CYS A 65 CYS A 105 1555 1555 2.45 SSBOND 4 CYS A 91 CYS A 118 1555 1555 2.52 SSBOND 5 CYS A 123 CYS A 169 1555 1555 2.52 SSBOND 6 CYS A 155 CYS A 181 1555 1555 2.64 SSBOND 7 CYS A 186 CYS A 229 1555 1555 2.68 SSBOND 8 CYS A 215 CYS A 241 1555 1555 2.55 SSBOND 9 CYS A 245 CYS A 296 1555 1555 2.63 SSBOND 10 CYS A 281 CYS A 306 1555 1555 2.75 SSBOND 11 CYS A 288 CYS A 326 1555 1555 2.68 LINK ND2 ASN A 143 C1 NAG B 1 1555 1555 1.46 LINK ND2 ASN A 164 C1 NAG A 329 1555 1555 1.46 LINK ND2 ASN A 174 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN A 234 C1 NAG D 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NDG B 2 1555 1555 1.41 LINK O4 NAG C 1 C1 NDG C 2 1555 1555 1.39 LINK O4 NDG C 2 C1 BMA C 3 1555 1555 1.33 LINK O3 BMA C 3 C1 BMA C 4 1555 1555 1.49 LINK O6 BMA C 3 C1 MAN C 5 1555 1555 1.64 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 LINK O4 NAG D 2 C1 MAN D 3 1555 1555 1.40 CISPEP 1 VAL A 16 PRO A 17 0 -0.50 CISPEP 2 TYR A 83 PRO A 84 0 -0.18 CISPEP 3 SER A 112 PRO A 113 0 -0.26 CRYST1 159.500 164.800 114.300 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006270 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006068 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008749 0.00000